Bay K8644is achemical compoundthat functions as anL-typecalcium channelagonist.Bay K8644 is used primarily as a biochemical research tool for this effect.[2]It is a structural analog ofnifedipinewith positive inotropic activity, and as an aromatic it is highly lipid soluble.
Names | |
---|---|
Preferred IUPAC name
Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate | |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.163.930 |
EC Number |
|
PubChemCID
|
|
CompTox Dashboard(EPA)
|
|
| |
| |
Properties | |
C16H15F3N2O4 | |
Molar mass | 356.301g·mol−1 |
Insoluble | |
Solubilityin other solvents | DMSO:184 mg/mL;methanolandethanol:63 mg/mL |
Hazards | |
GHSlabelling: | |
Warning | |
H315,H319 | |
P264,P280,P302+P352,P305+P351+P338,P321,P332+P313,P337+P313,P362 | |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
|
Mechanism of action
editBay K8644 targetsL-typevoltage-gatedcalcium channels.It is the first positive inotropic agent shown to act specifically and directly on calcium channels.[3]
References
edit- ^(±)-Bay K8644atSigma-Aldrich
- ^CID 2303fromPubChem
- ^Thomas, G; Chung, M; Cohen, CJ (January 1985)."A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent".Circ Res.56(1): 87–96.doi:10.1161/01.res.56.1.87.PMID2578336.